Proteomics on NGS: Game-Changing Immunoassay Technology to Increase Multiplexing and Throughput

October 09, 2020

Proteomics on NGS: Game-Changing Immunoassay Technology to Increase Multiplexing and Throughput

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

From June 2020

Olink Speakers: Ida Grundberg (CSO) and Erika Assarsson (Head of R&D).

You will learn:

About large-scale protein biomarker discovery studies for understanding of real-time human biology
How Olink high-multiplex immunoassay technology is combined with next-generation sequencing (NGS) readout
How 1,472 proteins can be measured with just 3 µL plasma/serum

The Scan

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

Faster, But Not Fast Enough

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

Featured White Papers

Accelerate COVID-19 Research with New Insights from World-Class Proteomics

Pilot Study: Serum Protein Biomarkers in Inflammatory Bowel Disease and Prediction of anti-TNF Response

Pilot Study for Identification of Biomarker Profiles in NASH Patients

Detection of Low-Abundance Serum Proteins Associated with Prediabetes for Predictive and Prognostic Purposes

Oct

29

Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov

17

Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

Menu